Stock listing

Euronext:ABLD ABL Diagnostics SA Action

Home listing (Euronext) of ABL Diagnostics SA

Follow ABL Diagnostics SA into a list and get an email when it puts out news.

Share price · EURONEXT:ABLD

€2.28 EUR +0.02 (+0.9%)

Close on Oct 30, 2026

Past year -49.1% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
€2.24 – €2.42 EUROct 30, 2026
Volume
10,284 sharesOct 30, 2026
Market cap
€36.64M EURAt the close on Oct 30, 2026 · price × 16.07M shares outstanding
52-week range
€2.10 – €5.00 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
€13,406 EURMedian day 3,773 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
ABL Diagnostics SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ABLD · Home€2.28 EUR+0.02 (+0.9%)10,284€2.26€2.42€2.24€2.26Close on Oct 30, 2026
Frankfurt:9BK0€2.12 EUR-0.10 (-4.5%)—€1.93€2.12€1.93€2.22Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · EURONEXT:ABLD · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€2.28+0.02+0.9%€2.26€2.42€2.2410,284
€2.26+0.02+0.9%€2.24€2.38€2.187,900
€2.24-0.16-6.7%€2.40€2.48€2.1812,615
€2.400.000.0%€2.40€2.52€2.405,894
€2.40+0.02+0.8%€2.38€2.40€2.38382
€2.380.000.0%€2.36€2.38€2.342,885
€2.38-0.02-0.8%€2.40€2.40€2.38610
€2.400.000.0%€2.40€2.48€2.383,773
€2.40-0.02-0.8%€2.52€2.52€2.388,858
€2.42-0.10-4.0%€2.50€2.50€2.422,307
€2.52-0.02-0.8%€2.56€2.56€2.482,581
€2.540.000.0%€2.52€2.54€2.482,403
€2.54-0.04-1.6%€2.56€2.56€2.465,473
€2.58+0.24+10.3%€2.38€2.60€2.3632,915
€2.34+0.04+1.7%€2.40€2.50€2.346,619
€2.30+0.10+4.5%€2.18€2.38€2.1810,648
€2.20-0.02-0.9%€2.22€2.22€2.104,782
€2.22+0.04+1.8%€2.24€2.24€2.162,022
€2.18+0.02+0.9%€2.16€2.18€2.162,757
€2.16-0.04-1.8%€2.12€2.18€2.103,388
€2.200.000.0%€2.24€2.26€2.124,110
€2.20-0.04-1.8%€2.24€2.24€2.121,267
€2.240.000.0%€2.10€2.26€2.108,057
€2.24-0.08-3.4%€2.30€2.30€2.241,002
€2.32+0.04+1.8%€2.28€2.32€2.28178
€2.280.000.0%€2.34€2.34€2.223,028
€2.28-0.14-5.8%€2.32€2.36€2.2013,211
€2.420.000.0%€2.42€2.42€2.341,182
€2.42+0.06+2.5%€2.44€2.46€2.327,963
€2.36-0.08-3.3%€2.50€2.50€2.349,019
€2.44-0.14-5.4%€2.56€2.56€2.445,295
€2.58+0.04+1.6%€2.60€2.64€2.522,231
€2.540.000.0%€2.56€2.68€2.544,545
€2.54+0.12+5.0%€2.46€2.54€2.426,083
€2.42-0.10-4.0%€2.54€2.54€2.426,018
€2.52+0.12+5.0%€2.54€2.60€2.4018,211
€2.40-0.18-7.0%€2.66€2.66€2.405,799
€2.58+0.14+5.7%€2.78€2.78€2.5826,733
€2.44+0.02+0.8%€2.44€2.44€2.4454
€2.420.000.0%€2.42€2.42€2.42517
€2.42+0.04+1.7%€2.34€2.42€2.344,647
€2.38+0.04+1.7%€2.38€2.40€2.38667
€2.34-0.12-4.9%€2.46€2.46€2.342,249
€2.46+0.02+0.8%€2.46€2.46€2.403,291
€2.44+0.10+4.3%€2.42€2.44€2.425,990
€2.34-0.02-0.8%€2.38€2.40€2.341,067
€2.36-0.04-1.7%€2.42€2.42€2.301,320
€2.400.000.0%€2.40€2.44€2.38969
€2.40+0.04+1.7%€2.38€2.40€2.382,700
€2.36+0.02+0.9%€2.36€2.36€2.342,007
€2.34+0.14+6.4%€2.20€2.40€2.207,374
€2.20-0.16-6.8%€2.36€2.36€2.2014,373
€2.36-0.04-1.7%€2.40€2.40€2.305,733
€2.40-0.10-4.0%€2.52€2.52€2.289,869
€2.50+0.06+2.5%€2.40€2.52€2.349,375
€2.44-0.08-3.2%€2.50€2.50€2.441,592
€2.52+0.06+2.4%€2.46€2.54€2.462,269
€2.46-0.04-1.6%€2.46€2.54€2.408,218
€2.50+0.08+3.3%€2.48€2.62€2.462,920
€2.42-0.06-2.4%€2.58€2.58€2.404,672
€2.48-0.02-0.8%€2.54€2.54€2.481,787
€2.50-0.08-3.1%€2.52€2.58€2.503,173
€2.58+0.06+2.4%€2.54€2.74€2.547,728
€2.52+0.06+2.4%€2.38€2.52€2.387,705
€2.46+0.04+1.7%€2.50€2.50€2.461,966
€2.420.000.0%€2.46€2.50€2.423,241
€2.42-0.04-1.6%€2.44€2.44€2.421,614
Ticker
Euronext:ABLD
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Euronext
Currency
EUR

What changed lately

Latest news

ABL Texcell Diagnostics Announces Termination of Vela Diagnostics Letter of Intent

Oct 20, 2026

Closed €2.40 (-0.8%) on Oct 20, 2026

ABL Texcell Diagnostics Strengthens the Foundations of a Stable Shareholder Base and Pursues Its Growth Strategy

Oct 19, 2026

Closed €2.42 (-4.0%) on Oct 19, 2026

ABL Texcell Diagnostics: Notice of Appeal by the Public Prosecutor Regarding the IntegraGen Transfer Judgment

Oct 16, 2026

Closed €2.52 (-0.8%) on Oct 16, 2026

ABL Texcell Diagnostics Strengthens Its Presence at Genopole and Opens a New Chapter in Precision Oncology With the Acquisition of IntegraGen’s Assets and Operations

Oct 12, 2026

Closed €2.34 (+1.7%) on Oct 12, 2026

ABL Texcell Diagnostics Announces Availability of All Invest Securities Research Flash Note #8

Oct 8, 2026

Closed €2.20 (-0.9%) on Oct 8, 2026

ABL Texcell Diagnostics Raises Its 2026 Revenue Guidance to €13.5 Million - €14.0 Million

Oct 1, 2026

Closed €2.20 (0.0%) on Oct 2, 2026

ABL TEXCELL Diagnostics relève son objectif de chiffre d’affaires 2026 à une fourchette de 13,5 M€ à 14,0 M€

Oct 1, 2026

Closed €2.20 (-1.8%) on Oct 1, 2026

ABL Texcell Diagnostics: Availability of the 2026 Half-Year Financial Report

Sep 30, 2026

Closed €2.20 (-1.8%) on Oct 1, 2026

Mise à disposition du rapport semestriel 2026

Sep 30, 2026

Closed €2.24 (0.0%) on Sep 30, 2026

ABL Texcell Diagnostics Reaches a New Strategic Milestone With a Proposed Acquisition of Vela Diagnostics' Activities in Singapore and the United States

Sep 21, 2026

Closed €2.42 (+2.5%) on Sep 22, 2026

All ABL Diagnostics SA news

Decks

ABL Diagnostics SA on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
41 in the last 12 months · 43 in all · newest Oct 20, 2026 · oldest 2025
Decks
1 deck · latest September 2021

Where ABL Diagnostics SA is listed

ListingExchangeCountryCurrency
Euronext:ABLD · Home listing · This pageEuronextFranceEUR
LS Exchange:A3DL82LS ExchangeGermanyEUR
Aquis:ABLDPAquisUnited KingdomEUR
Aquis:ABLDPAquisUnited KingdomEUR
Lang & Schwarz:A3DL82Lang & SchwarzGermanyEUR
Frankfurt:9BK0FrankfurtGermanyEUR
Stuttgart:9BK0StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about ABL Diagnostics SA.